Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Deformable Guidewire Facilitates Accurate Heart Valve Placement

By HospiMedica International staff writers
Posted on 28 Jan 2014
A novel malleable guidewire helps position prosthetic valves during transcatheter heart-valve implantation (TAVI) with greater precision.

The acWire guidewire is a single-use, fully disposable medical device that utilizes shape-memory alloy technology to enable the identification of cardiovascular structures with existing imaging methods. More...
The system is designed to provide the cardiologist with a continuous, clear, and precise landmark indicating where to implant the prosthetic valve during TAVI, shortening procedure time, reducing usage of radiation and contrast media, and improving clinical outcomes. The system can also be used in peripheral vascular catheterization procedures.

Once directed to the selected cardiovascular location, the active components are moved past the diseased valve and the guidewire is deformed under fluoroscopy to identify the desired valve cusps using radiopaque markers. The deformed guidewire opens up (like a flower) and is drawn back to the valve, aligning itself snugly just past the valve opening. The three radiopaque markers on the “petals” help the physician visualize how the device is positioned before placing the valve. The acWire guidewire is a product of MediValve (Kibbutz HaMa’apil, Israel), it is compatible with all valve models, and has been approved by the US Food and Drug Administration (FDA).

“I am impressed with the acWire technology and the promise it holds for positioning diagnostic and interventional devices during heart catheterization procedures. I look forward to evaluating the acWire in our clinic,” said Professor Carlos Ruiz, MD, PhD, chief of structural and congenital heart disease at North Shore LIJ- Hofstra University Hospital (Manhasset, NY, USA).

Aortic valve stenosis (AVS) compromises valve function and cardiac output, thereby reducing the amount of oxygen-rich blood received by key organs. Present in more than 25% of patients over age 65, it is most frequently caused by calcification of the aortic valve, and is associated with a 50% increased risk of cardiovascular events. Aortic valve replacement surgery is the recommended treatment for severe AVS. Yet, approximately 30% of the potential population is denied surgery due to the risks for elderly, weakened patients.

Related Links:

MediValve
North Shore LIJ- Hofstra University Hospital



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.